Cancer Research · 2004 · 147 citations · 48 references
MedicineCell BiologyOncologyBone MetabolismMetastasisTumor MicroenvironmentBone DevelopmentBone FormationBone MetastasisMetastatic Breast CancerOsteoclast BiologyOsteogenesisOsteolytic Bone DiseaseOsteolytic Bone LesionsOsteolytic Bone MetastasisOsteolytic Lesion FormationRunx2 Transcription FactorRunx2 Transcriptional RegulationRunx2-mediated RegulationTumor-bone Microenvironment
The osteolytic bone destruction associated with breast cancer skeletal metastases represents a serious and incurable clinical condition. However, the molecular mechanisms regulating tumor cell expression of factors involved in the generation of osteolytic disease remain elusive. We demonstrated recently that breast cancer cells express the Runx2 transcription factor, essential for bone formation and a regulator of skeletal homeostasis. Our experimental results demonstrate that perturbation of Runx2 regulatory function in tumor cells abolishes their ability to form osteolytic lesions in vivo. In vitro, we show that breast cancer cells inhibit osteoblast differentiation while concurrently enhancing osteoclast differentiation in marrow stromal cell cultures. Disruption of Runx2 activity abrogates both of these cancer cell-mediated effects on bone cells. These results demonstrate that Runx2 expression in breast cancer cells provides a molecular phenotype that enables the interactions between tumor cells and the bone microenvironment that lead to osteolytic disease.
48
THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.
Stephen A. Paget · The Lancet · 1889 · 5.1K citations
Medicine, Cancer Biology, Oncology +12
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Patricia Ducy, Rui Zhang, Valérie Geoffroy et al. · Cell · 1997 · 4.3K citations · Full text
G. David Roodman · New England Journal of Medicine · 2004 · 2.7K citations
Medicine, Oncology, Bone Metabolism +12